CLINCAL OUTCOMES WITH ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS WITH ADVANCED LUNG DISEASE

被引：0
|
作者：
Thompson, A. [1 ]
Djavid, R. [3 ]
Keating, C. [1 ]
DiMango, E. [1 ]
Altman, K. [2 ]
Gusman, E. [1 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Dept Nutr, Irving Med Ctr, New York, NY USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
655
引用
收藏
页码：S294 / S295
页数：2
相关论文
共 50 条
  • [31] Effect of elexacaftor-tezacaftor- ivacaftor modulator on lung structure in cystic fibrosis
    Fainardi, V.
    Skenderaj, K.
    Ciuni, A.
    Esposito, S.
    Sverzellati, N.
    Pisi, G.
    PULMONOLOGY, 2023, 29 (05): : 441 - 443
  • [32] Promising Results with Elexacaftor/Tezacaftor/Ivacaftor Use in Cystic Fibrosis Patients with Advanced Lung Disease: Beyond the Clinical Trial Inclusion Criteria
    Bowen, M.
    Alemayehu, M.
    Battle, E.
    Brown, A. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis
    Sheikh, Shahid
    Ho, Mai-Lan
    Eisner, Mariah
    Gushue, Courtney
    Paul, Grace
    Holtzlander, Melissa
    Johnson, Terri
    McCoy, Karen S.
    Lind, Meredith
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (12) : 1075 - 1082
  • [34] Long-term clinical outcomes of Elexacaftor/Tezacaftor/Ivacaftor therapy in adults with cystic fibrosis and severe lung disease
    Lucca, Francesca
    Savi, Daniela
    Barao, Marisol Ocampo
    Meneghelli, Ilaria
    Pauro, Francesca
    Signorini, Monica
    Cipolli, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [35] Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis
    Mitropoulou, Georgia
    Balmpouzis, Zisis
    Polojoux, Jerome
    Dotta-Celio, Jennifer
    Sauty, Alain
    Koutsokera, Angela
    RESPIRATORY MEDICINE AND RESEARCH, 2022, 82
  • [36] Isotretinoin for Elexacaftor/Tezacaftor/Ivacaftor (Trikafta®)-induced cystic acne in patients with Cystic Fibrosis
    Sathe, N.
    Rypka, K.
    Schultz, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S66 - S66
  • [37] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
    Smith, Megan
    Ryan, Kevin J.
    Gutierrez, Hector
    Sanchez, Luz Helena Gutierrez
    Anderson, Janaina Nogueira
    Acosta, Edward P.
    Benner, Kim W.
    Guimbellot, Jennifer S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
  • [38] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [39] Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients
    Garcia, Marta Solis
    Pelaez, Adrian
    Punter, Rosa Mar Gomez
    Lopez, Maria Criado
    Carbajal, Claudia Madrid
    Ancochea, Julio
    Bachiller, Jose Maria Eiros
    Hernandez, Ana Sofia Martin
    Rodrigo-Garcia, Maria
    Clemente, Marta Garcia
    Moreno, Rosa Ma Giron
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [40] 'Triple therapy' (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis
    Hu, May Khei
    Wood, Genna
    Dempsey, Owen
    POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1156) : 86 - 86
12345